By USFDA
Ajanta Pharma announced that its formulations facility at Dahej was inspected by USFDA from 03 April to 07 April 2017. At the end of the inspection, no Form 483 was issued to the Company.Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)